Literature DB >> 23871966

Mechanisms of HCV-induced liver cancer: what did we learn from in vitro and animal studies?

Ivan Rusyn1, Stanley M Lemon2.   

Abstract

Hepatitis C virus (HCV) is a cause of liver diseases that range from steatohepatitis, to fibrosis, cirrhosis, and hepatocellular carcinoma (HCC). The challenge of understanding the pathogenesis of HCV-associated liver cancer is difficult as most standard animal models used in biomedical research are not permissive to HCV infection. Herein, we provide an overview of a number of creative in vivo, mostly in the mouse, and in vitro models that have been developed to advance our understanding of the molecular and cellular effects of HCV on the liver, specifically with their relevance to HCC.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Cancer; Hepatitis C virus; Liver; Mechanisms; Models

Mesh:

Year:  2013        PMID: 23871966      PMCID: PMC3844040          DOI: 10.1016/j.canlet.2013.06.028

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  84 in total

Review 1.  Animal models for the study of hepatitis C virus infection and related liver disease.

Authors:  Jens Bukh
Journal:  Gastroenterology       Date:  2012-05       Impact factor: 22.682

2.  CD40 inhibits replication of hepatitis C virus in primary human hepatocytes by c-Jun N terminal kinase activation independent from the interferon pathway.

Authors:  Sibylle J Rau; Eberhard Hildt; Kiyoshi Himmelsbach; Robert Thimme; Takaji Wakita; Hubert E Blum; Richard Fischer
Journal:  Hepatology       Date:  2013-01       Impact factor: 17.425

Review 3.  Prospects for prophylactic and therapeutic vaccines against the hepatitis C viruses.

Authors:  Michael Houghton
Journal:  Immunol Rev       Date:  2011-01       Impact factor: 12.988

4.  Generation of a humanized mouse model with both human immune system and liver cells to model hepatitis C virus infection and liver immunopathogenesis.

Authors:  Moses T Bility; Liguo Zhang; Michael L Washburn; T Anthony Curtis; Grigoriy I Kovalev; Lishan Su
Journal:  Nat Protoc       Date:  2012-08-09       Impact factor: 13.491

Review 5.  Pathogenesis of hepatitis C-associated hepatocellular carcinoma.

Authors:  T Jake Liang; Theo Heller
Journal:  Gastroenterology       Date:  2004-11       Impact factor: 22.682

6.  Increased incidence of aflatoxin B1-induced liver tumors in hepatitis virus C transgenic mice.

Authors:  Emmanuelle Jeannot; Gary A Boorman; Oksana Kosyk; Blair U Bradford; Svitlana Shymoniak; Batbayar Tumurbaatar; Steven A Weinman; Stepan B Melnyk; Volodymyr Tryndyak; Igor P Pogribny; Ivan Rusyn
Journal:  Int J Cancer       Date:  2011-06-09       Impact factor: 7.396

7.  Steatosis and liver cancer in transgenic mice expressing the structural and nonstructural proteins of hepatitis C virus.

Authors:  Hervé Lerat; Masao Honda; Michael R Beard; Kim Loesch; Jiaren Sun; Yan Yang; Michiari Okuda; Rainer Gosert; Shu-Yuan Xiao; Steven A Weinman; Stanley M Lemon
Journal:  Gastroenterology       Date:  2002-02       Impact factor: 22.682

8.  Regulatory polymorphisms in the interleukin-18 promoter are associated with hepatitis C virus clearance.

Authors:  Ping An; Chloe L Thio; Gregory D Kirk; Sharyne Donfield; James J Goedert; Cheryl A Winkler
Journal:  J Infect Dis       Date:  2008-10-15       Impact factor: 5.226

9.  Methods for monitoring gene gun-induced HBV- and HCV-specific immune responses in mouse models.

Authors:  Gustaf Ahlén; Matti Sällberg; Lars Frelin
Journal:  Methods Mol Biol       Date:  2013

Review 10.  Global burden of cancers attributable to infections in 2008: a review and synthetic analysis.

Authors:  Catherine de Martel; Jacques Ferlay; Silvia Franceschi; Jérôme Vignat; Freddie Bray; David Forman; Martyn Plummer
Journal:  Lancet Oncol       Date:  2012-05-09       Impact factor: 41.316

View more
  20 in total

1.  Establishment of a Patient-Derived Xenograft Tumor From Hepatitis C-Associated Liver Cancer and Evaluation of Imatinib Treatment Efficacy.

Authors:  Mustafa Nazzal; Subhayan Sur; Robert Steele; Mousumi Khatun; Tapas Patra; Nancy Phillips; John Long; Ranjit Ray; Ratna B Ray
Journal:  Hepatology       Date:  2020-08       Impact factor: 17.425

Review 2.  Virus associated malignancies: the role of viral hepatitis in hepatocellular carcinoma.

Authors:  Amir Shlomai; Ype P de Jong; Charles M Rice
Journal:  Semin Cancer Biol       Date:  2014-01-20       Impact factor: 15.707

3.  A Phase II Randomized, Controlled Trial of S-Adenosylmethionine in Reducing Serum α-Fetoprotein in Patients with Hepatitis C Cirrhosis and Elevated AFP.

Authors:  Timothy R Morgan; Kathryn Osann; Teodoro Bottiglieri; Neville Pimstone; John C Hoefs; Ke-Qin Hu; Tarek Hassanein; Thomas D Boyer; Lorene Kong; Wen-Pin Chen; Ellen Richmond; Rachel Gonzalez; Luz M Rodriguez; Frank L Meyskens
Journal:  Cancer Prev Res (Phila)       Date:  2015-06-30

4.  HSD17B13 and other liver fat-modulating genes predict development of hepatocellular carcinoma among HCV-positive cirrhotics with and without viral clearance after DAA treatment.

Authors:  Michela E Burlone; Mattia Bellan; Matteo N Barbaglia; Ginevra Mocchetti; Venkata R Mallela; Rosalba Minisini; Cristina Rigamonti; Mario Pirisi
Journal:  Clin J Gastroenterol       Date:  2022-01-31

Review 5.  Multimodality imaging findings of infection-induced tumors.

Authors:  Moataz Soliman; Nicholas Guys; Peter Liu; Mariam Moshiri; Christine O Menias; Vincent M Mellnick; Hatice Savas; Mohamed Badawy; Khaled M Elsayes; Ayman H Gaballah
Journal:  Abdom Radiol (NY)       Date:  2022-09-07

6.  Chaperone-Mediated Autophagy Promotes Beclin1 Degradation in Persistently Infected Hepatitis C Virus Cell Culture.

Authors:  Yucel Aydin; Christopher M Stephens; Srinivas Chava; Zahra Heidari; Rajesh Panigrahi; Donkita D Williams; Kylar Wiltz; Antoinette Bell; Wallace Wilson; Krzysztof Reiss; Srikanta Dash
Journal:  Am J Pathol       Date:  2018-08-01       Impact factor: 4.307

Review 7.  Integrated stress response in hepatitis C promotes Nrf2-related chaperone-mediated autophagy: A novel mechanism for host-microbe survival and HCC development in liver cirrhosis.

Authors:  Srikanta Dash; Yucel Aydin; Tong Wu
Journal:  Semin Cell Dev Biol       Date:  2019-08-08       Impact factor: 7.727

Review 8.  Antiviral Activities of Human Host Defense Peptides.

Authors:  David C Brice; Gill Diamond
Journal:  Curr Med Chem       Date:  2020       Impact factor: 4.530

Review 9.  Hepatitis C Virus Infection Induces Autophagy as a Prosurvival Mechanism to Alleviate Hepatic ER-Stress Response.

Authors:  Srikanta Dash; Srinivas Chava; Yucel Aydin; Partha K Chandra; Pauline Ferraris; Weina Chen; Luis A Balart; Tong Wu; Robert F Garry
Journal:  Viruses       Date:  2016-05-23       Impact factor: 5.048

Review 10.  Utilization of animal models to investigate nonalcoholic steatohepatitis-associated hepatocellular carcinoma.

Authors:  Jian Wu
Journal:  Oncotarget       Date:  2016-07-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.